C. elegans Eats Its Own Intestine to Make Yolk Leading to Multiple Senescent Pathologies by Ezcurra, M et al.
ArticleC. elegans Eats Its Own Intestine to Make Yolk
Leading to Multiple Senescent PathologiesGraphical AbstractSENESCENT 
OBESITY
Yolk
AGING
SENESCENT
ATROPHY
Insulin/IGF-1
signaling
Autophagy
BIOMASS
CONVERSION
Embryo
Intestine
Yolky 
poolsYolkHighlightsd C. elegans consume their own intestine to synthesize yolk
and promote reproduction
d This causes diseases of aging, including atrophy of the
intestine and yolk steatosis
d Intestinal senescence in C. elegans is promoted by
autophagy
d Here destructive run-on of wild-type biological programs
causes senescent pathologiesEzcurra et al., 2018, Current Biology 28, 2544–2556
August 20, 2018 ª 2018 The Author(s). Published by Elsevier Ltd
https://doi.org/10.1016/j.cub.2018.06.035Authors
Marina Ezcurra, Alexandre Benedetto,
Thanet Sornda, ..., Eleanor Tyler,
Michael J. Wakelam, David Gems
Correspondence
david.gems@ucl.ac.uk
In Brief
Ezcurra, Benedetto et al. identify a
mechanism causing aging in C. elegans:
autophagy-dependent gut-to-yolk
biomass conversion. This is activated by
life-shortening insulin/IGF-1 signaling
and causes diseases of aging, including
intestinal atrophy and yolk steatosis. The
mechanism involved fits the recently
proposed hyper-function theory of aging..
Current Biology
ArticleC. elegans Eats Its Own Intestine to Make Yolk
Leading to Multiple Senescent Pathologies
Marina Ezcurra,1,2,7 Alexandre Benedetto,1,3,7 Thanet Sornda,1,4 Ann F. Gilliat,1 Catherine Au,1 Qifeng Zhang,5
Sophie van Schelt,1 Alexandra L. Petrache,1 Hongyuan Wang,1 Yila de la Guardia,1 Shoshana Bar-Nun,6 Eleanor Tyler,1
Michael J. Wakelam,5 and David Gems1,8,*
1Institute of Healthy Ageing and Department of Genetics, Evolution and Environment, University College London, London WC1E 6BT, UK
2School of Biological and Chemical Sciences, Queen Mary University of London, London E1 4NS, UK
3Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YW, UK
4Department of Biochemistry, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand
5The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK
6The George S. Wise Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, Israel
7These authors contributed equally
8Lead Contact
*Correspondence: david.gems@ucl.ac.uk
https://doi.org/10.1016/j.cub.2018.06.035SUMMARY
Aging (senescence) is characterized by the develop-
ment of numerous pathologies, some of which limit
lifespan. Key to understanding aging is discovery of
the mechanisms (etiologies) that cause senescent
pathology. In C. elegans, a major senescent pathol-
ogy of unknown etiology is atrophy of its principal
metabolic organ, the intestine. Here we identify a
cause of not only this pathology but also of yolky lipid
accumulation and redistribution (a form of senescent
obesity): autophagy-mediated conversion of intesti-
nal biomass into yolk. Inhibiting intestinal autophagy
or vitellogenesis rescues both visceral pathologies
and can also extend lifespan. This defines a disease
syndrome leading to multimorbidity and contrib-
uting to late-life mortality. Activation of gut-to-yolk
biomass conversion by insulin/IGF-1 signaling (IIS)
promotes reproduction and senescence. This illus-
trates how major, IIS-promoted senescent pathol-
ogies in C. elegans can originate not from damage
accumulation but from direct effects of futile,
continued action of a wild-type biological program
(vitellogenesis).
INTRODUCTION
Aging is a pervasive phenomenon across animal species and the
leading cause of human morbidity and death worldwide through
its associated senescent pathologies. Despite major advances
in the genetics of longevity, sparked by the identification of
long-lived insulin/insulin-like growth factor (IGF-)1 signaling
(IIS) pathway mutants in the roundworm Caenorhabditis elegans
[1–3], the proximate causes of aging remain unclear. One pro-
posed cause is stochastic molecular damage, for example due
to reactive oxygen species (ROS) [4], and consequent accumu-
lation of malfunctioning biomolecules, which IIS promotes [3].
However, it now appears that much aging-associated molecular2544 Current Biology 28, 2544–2556, August 20, 2018 ª 2018 The Au
This is an open access article under the CC BY license (http://creativedamage is more consequence than cause of senescent pathol-
ogies [5–7].
Another possible cause of aging is the continued and delete-
rious action (run-on, or hyper-function) in later life of wild-type
genes beyond their ‘‘intended purpose’’ [5, 8, 9]. This follows
from the evolutionary principle of antagonistic pleiotropy (AP),
where natural selection can favor gene variants that enhance
fitness in early life while promoting senescent pathologies in later
life, because the early-life benefits to the species outweigh the
late-life costs to the individual [8]. For example, IIS promotes
growth and reproduction in early life, and age-related pathol-
ogies in late life [6, 10]. Conversely, IIS inhibition increases life-
span and healthspan from worms to mammals [3], but can
slow development and reduce fitness.
The properties of long-lived mutants suggest that multiple ag-
ing pathologies can arise from common underlyingmechanisms.
This argues for complementing the standard lifespan genetics
approaches, that have been so fruitful in invertebrate bio-
gerontology, with the study of senescent pathologies, to
enhance our understanding of aging. Hence, lifespan that has
long been employed as a metric of an underlying aging process
(Figure 1A, top) may also be viewed as a function of one or more
life-limiting senescent pathologies. Which of themany extant pa-
thologies limits lifespan may vary between individuals, environ-
mental conditions, genders, and species (Figure 1A, bottom)
[11, 12], confounding studies of the genetics of lifespan. A pa-
thology-focused approach in aging model organisms can yield
new insights into the primarymechanism(s) of aging and help un-
derstand how genes control lifespan.
C. elegans exhibits a plethora of unusually severe senescent
pathologies, including degeneration of the pharynx, tumors in
the uterus, atrophy of the intestine and gonad, and steatotic lipo-
protein redistribution [9, 13–16], thus providing ample raw mate-
rial for study. Here we focus on senescent pathology in the main
C. elegans metabolic organ, the intestine, which in addition ful-
fills the functions of liver and adipose tissue and is a key site of
action for IIS-mediated effects on lifespan [17]. To this end, we
employed a developmental pathology approach, quantifying
the temporal evolution of gut pathology at anatomical, cellular,
and molecular levels, and identified a novel pathophysiologicalthor(s). Published by Elsevier Ltd.
commons.org/licenses/by/4.0/).
Figure 1. Early, Rapid, and Synchronous Development of Senescent Pathologies during C. elegans Adulthood
(A) View of the position of senescent pathology in aging upon which this study is based. Top: lifespan is widely used as a metric of an underlying process, aging.
Bottom: lifespan is additionally a function of life-limiting senescent pathologies, with differing and condition-dependent effects on late-life mortality.
(B) In selfing wild-type hermaphrodites (20C), adulthood is characterized by 4–5 days of reproduction,12 days during which the gross pathologies studied here
develop, and a 20-day median lifespan.
(C) Many senescent pathologies develop in parallel from early adulthood, reaching maximum severity by around day 14.
(D) 14-day-old hermaphrodites (center and right) exhibit an atrophied intestine (I; hollow arrowheads), an enlarged lumen (L; black arrowheads), and large
pseudocoelomic lipoprotein pools (PLPs) compared to 1-day-old worms (left).
(E) PLP accumulation score and intestinal atrophy correlate at the individual worm level (day 7).
(F) The evolution of PLP accumulation mirrors intestinal atrophy, and their severities are strongly correlated at a population level Animals were maintained on
E. coli OP50 at 20C without FUDR.
See also Figure S1.mechanism: autophagy-dependent gut-to-yolk biomass conver-
sion, run-on of which causes multiple visceral pathologies,
including intestinal atrophy. These results are consistent with
the account provided by Williams [8] and Blagosklonny [5, 9] of
how antagonistic pleiotropy is enacted in terms of proximate
mechanisms: destructive run-on of biological programs speci-
fied by wild-type genes.
RESULTS
Major Senescent Pathologies Develop in Early to Mid-
Adulthood
Various senescent pathologies have been documented in
C. elegans, but details of their developmental timing, particularly
in relation to one another, remain sparse. In humans, diseases of
aging (e.g., cardiovascular, neurodegenerative, cancer) increase
mainly toward the end of life. We asked: is this true of C. eleganstoo? To this end, we monitored development of uterine tumors,
gonadal atrophy, deterioration of the pharynx (foregut), yolky li-
poprotein pools in the body cavity (pseudocoelom), and intesti-
nal atrophy. Wild-type (N2) hermaphrodites were aged under
standard conditions (nematode growth medium [NGM] agar
plates, Escherichia coli OP50 bacteria as a food source, 20C)
and imaged using Nomarski microscopy at intervals from day 1
to 21 (d1–d21) of adulthood, and the severity of pathologies
was quantified (Figures S1A–S1E). Against expectation, senes-
cent pathologies developed not toward the end of life but
much earlier, starting at around the time of self-sperm depletion
(d3–d4) and reaching peak severity at around d10–d12 of adult-
hood, prior to median lifespan (Figure 1B). Moreover, the various
pathologies developed in relative synchrony, revealing an aging
syndrome (Figure 1C). In particular, development of intestinal at-
rophy and pseudocoelomic lipoprotein pool (PLP) accumulation
(Figure 1D) were strongly coupled in all growth conditions testedCurrent Biology 28, 2544–2556, August 20, 2018 2545
(Figure S2A), showing correlation within individuals (Figures 1E
and S2B) and strikingly close temporal correlation (Figure 1F).
This suggested a possible common etiology of these two pathol-
ogies, which we investigated further, beginning with a closer ex-
amination of the two pathologies individually.
Accumulation of Pseudocoelomic Lipoprotein Pools
(PLPs) as a Form of Senescent Obesity in C. elegans
PLPs have been previously identified as yolk, as they contain the
yolk protein (vitellogenin) VIT-2/YP170 [13, 14]. We verified this
by co-localization within the pools of both VIT-2 and VIT-6 (the
sole source of YP115 and YP88 in worms; Figure S2C). Consis-
tent with PLPs being yolk, preventing oocyte yolk uptake by
RNAi against the receptor rme-2 accelerated pool growth,
whereas males (which do not make yolk) did not accumulate
PLPs (Figures 2A and 2B). The magnitude of the pools, which
can grow to fill the entire body cavity (Figure 1D, right), and the
lipid content of yolk imply a major senescent buildup of lipids
in C. elegans. Fluorescent labeling of neutral lipids using
gentle-fix Bodipy staining [18] confirmed the presence of lipids
in PLPs, which co-localized with VIT-6::mCherry (Figures 2C
and S2D). Moreover, transmission electron microscopy (TEM)
of mid-body sections defined a 3.8-fold increase in lipid organ-
elle area between day 1 and 7 of adulthood (Figure 2D, left),
largely attributable to a 15-fold increase in pool area (Figure 2D,
center) but also to a 3-fold increase in intracellular lipids (Fig-
ure 2D, right). During the same period, a striking 8-fold increase
in triacylglyceride (TAG) content was detected, using biochem-
ical assays and lipidomic analysis (Figures 2E, S3A, and S3B;
Data S1 and S2). Thus, aging C. elegans, by accumulating large
amounts of ectopic fat within the pools, become steatotic [16].
Run-On of Yolk Synthesis Promotes PLP Generation
PLP accumulation has been suggested to result from run-on of
lipoprotein production after cessation of egg laying (continued
source but loss of sink) [14]. To characterize this putative vitello-
genic open faucet, we monitored yolk protein (YP) levels
throughout life (days 1–20). This revealed a sustained increase
in YP content until day 14, and a maximal 7-fold increase in
YP170 (Figures 2F and S4A). Blocking YP accumulation by
vit-5/6 double RNAi (Figures S4A) or inhibiting lipid synthesis
by RNAi against the fatty acid desaturases fat-6 and fat-7
reduced pool accumulation (Figures 2G and 2H), confirming
that PLPs stem from run-on of lipoprotein synthesis.
Conversion of Intestinal Biomass into Yolk Causes
Organ Atrophy
Whereas cessation of egg laying after sperm depletion is a pre-
requisite for YP accumulation [19], post-reproductive accumula-
tion must reflect continued vitellogenin synthesis. It is notable
that C. elegans is able to sustain heavy production of lipoprotein
to advanced ages, despite the decline with age in feeding rate
[20] (Figure S4B). We also noted that although C. elegans total
protein content plateaus at day 5, the amount of vitellogenin as
a proportion of overall protein continues to increase for several
more days; strikingly, vitellogenin eventually forms 30%–40%
of total worm protein content (Figures 3A, 3B, and S4C). These
observations, taken together with the coupling between intesti-
nal atrophy and pool accumulation (Figures 1E and 1F) in all2546 Current Biology 28, 2544–2556, August 20, 2018growth conditions tested (altered temperature or bacterial diet,
presence of 5-fluoro-2-deoxyuridine (FUDR; Figure S2A), and
the fact that the intestine is the site of yolk production [21] sug-
gest a new hypothesis: that the intestine consumes its own
biomass to enhance capacity for yolk production.
Consistent with this hypothesis, inhibition of YP production by
vit-5/6 RNAi or by mutation of upstream activators of yolk syn-
thesis (ceh-60 and lrp-2) [22] alleviated both pool accumulation
and intestinal atrophy (Figures 2G, 3C, and S4D). Moreover, in
wild-type males, which do not make yolk, neither PLP accumu-
lation nor intestinal atrophy was observed. However, induction
of ectopic YP production inmales bymutation ofmab-3was suf-
ficient to induce both pathologies (Figures 3D and 3E). Corrobo-
rating the idea that intestinal mass is converted into lipoprotein,
analysis of lipid distribution by TEM and Bodipy staining [18] re-
vealed that the proportion of intestinal lipids versus PLP lipids
decreases between day 1 and 7 (Figures 3F, 3G, and S4E),
whereas labeling of intestinal lipid organelles with GFP-tagged
DHS-3 (dehydrogenases, short chain-3) [23] becomes patchy
and reduced (Figure 3H). Consistent with this, inhibition of YP
production by vit-2 RNAi increases intestinal lipid content [24].
We also considered two alternative scenarios. First, steatosis
rather than yolk synthesis might indirectly cause intestinal atro-
phy. Arguing against this, rme-2 RNAi, which increases steatosis
by inhibiting yolk uptake by oocytes, did not aggravate intestinal
atrophy (Figure 3I). Second, the intestinal lumen of older her-
maphrodites often appears packed with E. coli, raising the pos-
sibility that growth of lumenal bacteria promotes gut distension
[13]. However, inhibition of E. coli proliferation by antibiotics or
UV irradiation did not lessen the magnitude of intestinal atrophy
and lumenal expansion, although they were delayed (Figures
S4F and S4G), ruling out bacterial growth as the main driver of
intestinal atrophy.
Altogether, these results strongly suggest that a single etiol-
ogy, intestinal biomass conversion into lipoprotein, causes three
comorbidities in senescing C. elegans: intestinal atrophy, extra-
cellular yolk accumulation, and steatotic lipid redistribution.
Autophagy Promotes Intestinal Atrophy and PLP
Accumulation by Gut Biomass Conversion
But how does this biomass conversion occur? Such a process
would require bulk breakdown and recycling of cellular compo-
nents, a role typically fulfilled by autophagy (macroautophagy,
specifically) in contexts of starvation, ecdysozoan molting, and
metamorphosis [25]. Notably, levels of autophagy appear to be
high in the intestine of adult hermaphrodites [26]. To test this hy-
pothesis, we first examined mutants defective in induction of
autophagy (atg-13(bp414)), autophagosomal vesicle elongation
(atg-4.1(bp501)), and Atg9p retrieval (atg-2(bp576) and atg-
18(gk378)), and found that all four mutations reduced both gut
atrophy and pool accumulation (Figure 4A). This implies that
autophagy promotes both pathologies.
To explore how autophagy inhibition suppresses gut atrophy,
we tested effects of adult-specific inhibition of autophagy by
atg-13 RNAi, selecting atg-13 [27] because, as an upstream
regulator of autophagy, its inhibition may be less likely to induce
deleterious pleiotropic effects through accumulation of
abnormal autophagosomes. Using an intestine-specific reporter
of autolysosome formation [26], we first obtained evidence that
Figure 2. Pathophysiology of Yolk Steatosis in Aging C. elegans
(A) Inhibition of yolk uptake by rme-2 RNAi aggravates PLP accumulation; N = 2 trials.
(B) Absence of yolk synthesis prevents PLP accumulation in aging males; N = 2 trials.
(C) PLPs contain neutral lipids and yolk proteins YP115/YP88 as revealed by co-localization (far right) of Bodipy (center-left) and VIT-6::mCherry (center-right).
(D) Estimation of lipid content from measuring intracellular yolk particle (Yp), lipid droplet (LD), and extracellular PLP areas in transmission electron micrographs
(TEMs) ofmid-body sections reveals a 3.75-fold increase between day 1 and 7 (left), mostly explained by a 15-fold rise in combined PLP area (center) but also by a
3-fold increase in intracellular lipids (right).
(E) 8-fold increase in TAG content between day 1 and 7 of adulthood.
(F) Lifetime increase in vitellogenins, from SDS-PAGE analysis of wild-type worm lysates.
(G) Inhibition of vitellogenin synthesis reduces PLP accumulation.
(H) Inhibition of lipid synthesis by fat-6/7 RNAi reduces PLP accumulation.
Wormswere raised on E. coliBOP50, except for (A), (G), and (H), where E. coliK12HT115was used. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figures S2 and S3
and Data S1 and S2.adult-specific atg-13 RNAi reduces intestinal autophagy (Fig-
ure 4B). We next found that adult-specific atg-13 RNAi reduced
both yolk pool accumulation and intestinal atrophy when broadly
applied (Figure S5A), but also when restricted to the adult intes-
tine (Figure 4C). Moreover, adult-limited atg-13 RNAi rescued
pathologies induced by intestinal feminization in mab-3 males
(Figure 4D). Conversely, gut-specific transgenic rescue of the
atg-13(bp414) mutation restored intestinal atrophy without a
detectable increase in PLP accumulation (Figure S5B).Abrogation of atg-13, atg-4.1, atg-9, atg-2, or atg-18 bymeans
of mutation or RNAi also impeded senescent lipid redistribution,
as shown by DHS-3::GFP [23], Bodipy [18], and TEM lipid organ-
elle analyses (Figures 5, S5C, and S5D). Adult-specific RNAi of
atg-2, atg-4.1, atg-9, and atg-18, like that of atg-13, also reduced
gut atrophy (Figure S5E). Moreover, atg-13(bp414) largely sup-
pressed age changes in lipid profiles (Figure S5F; Table S1). As
autophagosomes consume endomembranes, we followed gut
intracellular markers for Golgi and early, late, and recyclingCurrent Biology 28, 2544–2556, August 20, 2018 2547
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Figure 3. Evidence of Conversion of Intestinal Biomass into Yolk
(A) Total protein content of wild-type worms across the course of a lifetime, peaking at day 6.
(B) The proportion of YP to total proteins increases 4-fold between day 1 and 7 (gel densitometric analysis).
(C) Inhibition of yolk synthesis by vit-5/6 RNAi (left) or lrp-2 or ceh-60mutations (right) rescues intestinal atrophy; N = 2 trials. All mutants are significantly different
from wild-type (p < 0.05) at 2 or more time points.
(D) Wild-type males show no gut atrophy (left), whereas yolk-producing mab-3(mu15) males exhibit PLPs and gut atrophy (right).
(E) Quantitation of PLP accumulation (top) and gut atrophy (bottom) inmab-3males; N = 2 trials. Asterisks indicate statistical comparison betweenmab-3; him-5
males and him-5 or wild-type males.
(F) TEM of mid-body sections reveals a redistribution of intestinal lipids to other tissues between day 1 and 7.
(G) Lipid redistribution confirmed by analysis of neutral lipid staining by Bodipy.
(H) Numbers of DHS-3::GFP-marked lipid droplets decrease with age.
(I) Inhibition of yolk uptake by rme-2 RNAi, which aggravates PLP accumulation, does not affect intestinal atrophy.
Trials were conducted at 20C, no FUDR (A–E) or 25C with FUDR (F–I). *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S4.endosomes during early aging. We failed to see salient age-
related changes in endosomal staining, but we did observe a
significant reduction in intestinal Golgi labeling by alpha-manno-
sidase II-GFP at day 10 [28], which was rescued by atg-13 RNAi2548 Current Biology 28, 2544–2556, August 20, 2018(Figure S5G). This is consistent with the hypothesis that autopha-
gosomes compete with the Golgi apparatus for endomembrane
availability [29]. These results suggest that atg-13-mediated lip-
ophagy promotes the conversion of intestinal lipids into yolk
Figure 4. Evidence that Intestinal Autophagy Promotes Intestinal Atrophy and PLP Accumulation
(A) Mutations in autophagy genes reduce age-associated PLP accumulation (left) and limit intestinal atrophy (right); N = 2 trials. All mutants were significantly
different (p < 0.05) at 2 or more time points.
(B) atg-13 RNAi suppresses the age increase in intestinal autophagy (p = 0.009, 2-way ANOVA). mFP/dFP, monomeric fluorescent protein, dual fluorescent
protein.
(C) Adult-limited atg-13 RNAi targeted to the gut reduces age-associated PLP accumulation (left) and intestinal atrophy (right); N = 2 trials.
(D) Adult-limited atg-13 RNAi rescues PLP accumulation and gut atrophy in mab-3 males; N = 3 trials.
*p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S5.lipids destined for export. Taken together, our results suggest
that autophagy promotes gut-to-yolk biomass conversion, lead-
ing to senescent multimorbidity.
Gut Biomass Conversion Involves a Trade-Off between
Fitness and Late-Life Health
We then explored whether gut-to-yolk biomass conversion can
contribute to late-life mortality. Analysis of age-specific pathol-
ogy measures and survival in individual worms (Figure 6A, left)
and in various strains and growth conditions (Figure 6A, right)
identified a strong positive correlation between lifespan and in-
testinal width in mid-life, suggesting that intestinal atrophy can
contribute to mortality. Inhibiting gut-to-yolk biomass conver-
sion by atg-13 RNAi targeted to the whole adult animal or to
the intestine alone extended lifespan at 25C (+21.3%
and +5.4%, respectively, p < 0.0001 in each case, log rank
test; Figures 6B and 6C), but not at 20C (Data S3). At 25C, life-
span was also increased by adult-limited, whole-worm RNAi of
atg-2 (+9.7%, p < 0.0001) but not atg-18 (Figure S5H). These re-
sults could reflect condition dependency with respect to which
senescent pathologies are life limiting (Figure 1A). vit-5/6 RNAi
also significantly increased lifespan (+12.8%, p < 0.0001; Fig-
ure 6D; Data S3), as reported for vit-5 RNAi [30], whereas
rme-2 RNAi, which increases PLP accumulation (Figure 2A),
reduced lifespan (11.6%, p < 0.0001; Figure S5I; Data S3).
fat-6/7 RNAi caused marked acceleration in gut atrophy rate
(Figure S5J), which may reflect increased biomass conversion
in response to reduced de novo fatty acid synthesis, and also
reduced lifespan (14.0%, p < 0.0001; Figure 6E). Similarly,
mab-3(mu15) males, which have severe intestinal atrophy,were short lived (39.6%, p < 0.0001), whereasmab-3 hermaph-
rodites were not (Figure 6F; Data S3). Taken together, these
results support the view that intestinal atrophy and PLP accumu-
lation can contribute to late-life mortality.
Although vit-5/6 RNAi, atg-13 RNAi, and atg-13(bp414) had lit-
tle effect on brood size, consistent with the normal fertility of
ceh-60 and lrp-2 mutants [22], vit-5/6 RNAi in atg-13(bp414)
worms caused near-sterility (Figure 6G). These results suggest
that high levels of autophagy in the intestine promote fitness
by supporting yolk production in early adulthood (during repro-
duction), whereas run-on of intestinal autophagy contributes to
gut atrophy and pool formation in later life (post-reproduction).
This is further supported by the fact that mated hermaphrodites
with increased brood sizes display accelerated gut atrophy (Fig-
ure S6A) consistent with life-shortening effects of exposure to
males [31] but exhibit delayed PLP accumulation, most likely
due to prolonged egg laying (increased yolk sink; Figure S6B).
Exposure to male secretions alone did not affect either visceral
pathology (Figures S6C–S6H), consistent with recent evidence
that exposure to males shortens lifespan by two distinct mecha-
nisms [31]. All this supports the existence of a trade-off between
beneficial effects of biomass conversion on reproductive fitness
and later-life pathogenic effects.
Insulin/IGF-1 Signaling (IIS) Promotes Gut-to-Yolk
Biomass Conversion
Another factor that enhances evolutionary fitness at the expense
of senescent pathologies and lifespan shortening is IIS, which
promotes reproductive development [3, 13]. Hence, the wild-
type daf-2 insulin/IGF-1 receptor allele is a good example ofCurrent Biology 28, 2544–2556, August 20, 2018 2549
Figure 5. Inhibition of atg-13 Reduces Age-Associated Lipid Redistribution
(A) Adult-limited atg-13 RNAi delays the age-associated decrease in DHS-3::GFP-labeled intestinal lipid droplets. Images showing labeling of intestinal lipid
droplets using DHS-3::GFP in control and atg-13 RNAi animals (left). Quantification of DHS-3::GFP-labeled intestinal lipid droplets (right).
(B) Age-associated lipid redistribution is inhibited by atg-13(bp414). Bodipy staining of neutral lipids in control and atg-13 RNAi animals reveals preservation of
Bodipy-labeled intestinal lipid content (cf. Figure 3G).
(C) Quantification of lipidic organelles using TEM. Age-related increase in lipidic area is suppressed by atg-13(bp414) (top). Relative intestinal lipidic organelle
content is preserved during aging in atg-13(bp414) compared to wild-type (middle and bottom).
(D) TEM images at 3,0003 (top) and 10,0003 (bottom) of wild-type (left and center) and atg-13(bp414) (right) worm sections on day 7 of adulthood. atg-13(bp414)
worms have reduced PLPs and increased intestinal lipid droplets compared to wild-type.
*p < 0.05, ***p < 0.001. See also Table S1.antagonistic pleiotropy (AP) [10]. The proximate mechanisms
downstream of IIS that account for effects on lifespan have
been sought for many years, e.g., by detailed characterization
of IIS-regulated genes, yet remain uncertain. One possibility is
that gut-to-yolk biomass conversion is one such proximate
mechanism. Consistent with this idea, mutation of daf-2 not
only extends lifespan [3] but also rescues senescent multimor-2550 Current Biology 28, 2544–2556, August 20, 2018bidity, including YP increase, PLP accumulation, intestinal atro-
phy, and lipid redistribution (Figures 7A–7D and S7A–S7C)
[13, 19], which requires the DAF-16/FoxO transcription factor
(Figures 7C, 7D, and S7C) [3, 19].
Another intervention that extends lifespan in a daf-16-depen-
dent manner is removal of the germline, which also triggers
DAF-16 nuclear localization most prominently in intestinal cells
Figure 6. Intestinal Autophagy Promotes Optimal Reproduction at the Expense of Longevity
(A) Correlation between intestinal atrophy and lifespan. Left: individual worm analysis, day 7 gut width. Right: worm population analysis, different treatments
affecting lifespan, day 6/7 gut width.
(B) Adult-limited atg-13 RNAi targeted to the whole animal extends lifespan; N = 6 trials.
(C) Adult- and gut-limited atg-13 RNAi extends lifespan; N = 5 trials.
(D) Inhibition of yolk synthesis extends lifespan; N = 5 trials.
(E) Inhibition of fatty acid synthesis shortens lifespan; N = 2 trials. Previously, no effect of fat-6(tm331); fat-7(wa36) on lifespan was detected [51]; the reason for the
different effects of fat-6/7 RNAi and mutation remains unknown.
(F)mab-3; him-5males are short lived butmab-3; him-5 hermaphrodites are not; N = 2 trials. Reduced lifespan ofmab-3males could be attributable to the visceral
or the tail abnormalities.
(G) Adult-limited vit-5/6 RNAi (left) or atg-13 RNAi and atg-13mutation (center) each modestly reduces brood size, but combined vit-5/6 RNAi and atg-13(bp414)
cause sterility (right); N = 2 trials.
Experiments were performed at 20C without FUDR (A and F), 25C without FUDR (D, E, and G), and 25C with FUDR (B and C). *p < 0.05, ***p < 0.001. See also
Figure S6 and Data S3.[3]. Blocking germline development using glp-4(bn2ts) also de-
layed intestinal atrophy, and this effect was largely daf-16
dependent (Figure S7D), suggesting that DAF-16 suppresses
gut-to-yolk biomass conversion in this context also. Moreover,
in daf-16(mgDf50) mutants, atg-2, atg-13, and atg-18 RNAi
rescued intestinal atrophy to a similar extent as in wild-type
worms (Figure 7E, top), whereas atg-2 and atg-13 RNAi
extended mean lifespan (+11.7% and +12.6%, respectively,
both p < 0.0001; Figures 7E and S7E; Data S3), suggesting
that autophagy acts in parallel to or downstream of DAF-16.Full understanding of how IIS regulates gut-to-yolk biomass con-
version will require further study.
DISCUSSION
These findings support a model in which the run-on of reproduc-
tive functions promotes senescent pathogenesis in C. elegans
hermaphrodites. This involves IIS-driven and autophagy-medi-
ated conversion of intestinal biomass into yolk and, subsequently,
steatotic yolk pools (PLPs). The model proposes a single etiologyCurrent Biology 28, 2544–2556, August 20, 2018 2551
Figure 7. Reduced Insulin/IGF-1 Signaling
Inhibits Gut-to-Yolk Biomass Conversion
(A) PLP accumulation (left) and intestinal atrophy
(center) are suppressed modestly by daf-2(e1368)
and strongly by daf-2(e1370), which also has a
larger effect on lifespan (right), confirming findings
in a recent study [52].
(B) YP levels and YP as proportion of total protein
in daf-2(e1368) (left) and daf-2(e1370) (right) (cf.
Figures 2F and 3B).
(C) PLP accumulation (top) and intestinal atrophy
(bottom) in daf-2(e1370) require daf-16; N = 2
trials.
(D) Age-associated neutral lipid redistribution
(Bodipy) is suppressed in daf-2(e1370) mutants,
and this requires daf-16. *p < 0.05, ***p < 0.001,
&&&p < 0.001, compared to age-matched daf-16,
daf-16; daf-2, or wild-type (cf. Figure 3G).
(E) RNAi of atg-2, atg-13, and atg-18 all suppress
intestinal atrophy (top), whereas atg-2 and atg-13
also increase lifespan (bottom; p < 0.01 all trials;
N = 2 and 5, respectively) in a daf-16(mgDf50)
mutant (25C, FUDR). ***p < 0.001.
(F) Proposed mechanism of antagonistically
pleiotropic action of IIS promoting reproduction at
the expense of senescent pathologies, through
gut-to-yolk biomass conversion.
See also Figure S7.for several major comorbidities of worm aging, and identifies a
mechanism by which IIS, through inhibition of DAF-16, can cause
senescent atrophy of the hermaphrodite intestine (Figure 7F).
Themechanisms proposed here differ from the traditional view
of aging as caused by homeostatic imbalance and damage
accumulation. Here instead, persistence of function specified
by wild-type genes beyond their ‘‘intended’’ purpose actively
drives senescent pathogenesis, consistent with the hyper-func-
tion model of AP action [5, 8] rather than the disposable soma
model [32].
Coordinated Development of Senescent Pathologies in
Mid-Adulthood
A survey of patterns of development of major senescent pathol-
ogies revealed that these appear not, as expected, near the end2552 Current Biology 28, 2544–2556, August 20, 2018of life, but in mid-adulthood. The overall
pattern suggests a mid-life phase charac-
terized by vigorous development of pa-
thologies, ending at around d10–d12 of
adulthood (Figures 1B and 1C). The major
anatomical changes that result most likely
contribute to reported age changes in
C. elegans expression profiles, e.g., levels
of intestinal proteins decline with age [33].
Thus, many age changes in mRNA and
protein level may be the consequence
rather than the cause of pathogenic pro-
cesses such as gut-to-yolk biomass con-
version. One possibility is that when the
major pathologies have reached their
developmental endpoints around d10–
d12 the nematodes are, as a conse-quence, terminally ill and spend the rest of their lives slowly
dying.
PLPs as a Form of Senescent Obesity in C. elegans
Yolk accumulation in adult C. elegans has been described
previously, but not its full extent during aging. Here we report
that age increases in vitellogenin levels reach 7-fold that of
young adults, forming up to 30%–40% of total worm protein,
whereas TAG levels increase 8-fold. The presence of large
yolky pools staining with the lipid dye Bodipy implies that
such pools are major extracellular lipid deposits, helping to
account for the age increase in TAG. The severely steatotic
nature of elderly C. elegans described here and elsewhere
[16] could have been overlooked previously due to the use
in lipid staining protocols of fixation methods with dehydration
steps; here we used a gentle staining method without such
steps [18].
We postulate that PLPs develop by run-on of yolk lipid produc-
tion (Figure 7F), but cannot exclude a contribution from lipids
released by degeneration of other organs such as the distal
gonad [9]. The age-dependent accumulation and gross appear-
ance of the PLPs suggest that they represent a form of patholog-
ical senescent obesity in C. elegans. Consistent with this,
lifespan was slightly reduced by knockdown of expression of
the yolk receptor rme-2, which accelerated PLP accumulation
without affecting intestinal atrophy (Figures 2A, 3I, and S5I). A
possible explanation for PLP toxicity is late-life ectopic deposi-
tion, e.g., in muscle and epidermis (data not shown) [14], due
to PLP endocytosis as part of a senescent redistribution of fat
stores. Such age-associated redistribution of fat is reminiscent
of pathogenic shifts in fat distribution that occur in aging mam-
mals, underscoring the potential of C. elegans as a model for
investigating pathologies of fat metabolism.
Gut-to-Yolk Biomass Conversion Causes Intestinal
Senescence
In mammals, senescence causes diverse pathologies. Important
questions are: to what extent do multiple senescent pathologies
originate from common etiologies [12]? And: what is the nature of
these etiologies? Here we provide an example of how one etiol-
ogy, gut-to-yolk biomass conversion, promotes two major se-
nescent pathologies: intestinal atrophy and yolk accumulation,
each of which may lead to further pathologies. For example,
yolk accumulation promotes uterine tumor development [34].
The intestine is the major somatic internal organ in C. elegans,
also serving as liver and adipose tissue. As C. elegans hermaph-
rodites get old, the intestine undergoes severe deterioration [15],
most likely impairing worm viability. Consistent with this, the
extent of intestinal atrophy in early tomid-adulthood is predictive
of lifespan (Figure 6A). Furthermore, the lifespan-controlling tran-
scription factor DAF-16 exerts its effects in the intestine [17].
Moreover, intestinal necrosis is a key event in organismal death
[35]. All this is in agreement with the view that intestinal senes-
cent pathology can be life limiting to C. elegans. Consistent
with this, we document here that lifespan can be increased by
treatments that reduce intestinal atrophy (e.g., inhibition of
genes promoting vitellogenesis and autophagy) and reduced
by treatments that increase intestinal atrophy (blocking de
novo fat synthesis and induction of yolk synthesis in the
male gut).
Autophagy as a Promoter of Gut-to-Yolk Biomass
Conversion and Intestinal Pathology
Our findings suggest that autophagy promotes intestinal atrophy
and yolk steatosis, consistent with gut-to-yolk biomass conver-
sion. Yet this result was unexpected, insofar as the role of auto-
phagy in aging is often viewed as a protective one, congruent
with the idea that aging results from molecular damage: by
removing damaged cellular components, autophagy helps to
maintain the cell in a youthful state [36]. Consistent with this, in-
hibition of genes encoding autophagy-related proteins can
reduce extended longevity in C. elegans, e.g., when induced
by mutation of daf-2, dietary restriction, and germline loss [36].
Moreover, it has been proposed that autophagy is increased indaf-2 mutants, contributing to their increased longevity
[36, 37]. Yet our findings imply that gut-to-yolk biomass conver-
sion is reduced in daf-2 mutants, suggesting reduced auto-
phagy. How may such different claims be reconciled?
The idea that autophagy might promote rather than suppress
senescent changes is not in itself contentious. Autophagy can
enhance as well as inhibit the development of pathologies,
including senescent ones [38]. For example, production of the
senescence-associated secretory phenotype (SASP) proteins
in mammalian cells is promoted by autophagy [39], there playing
a role somewhat similar to that inC. elegans yolk production pro-
posed here.
Inhibition of genes involved in autophagy has been observed
either to reduce or increase C. elegans lifespan, or to have no ef-
fect on it [36, 40, 41] (this study). We postulate that the pathol-
ogies that limit life vary with culture conditions and genotype
(Figure 1A), and between species. Thus, the effect on lifespan
of inhibiting autophagy will depend on whether life-limiting pa-
thologies are inhibited or enhanced by autophagy. For example,
we found that atg-13 RNAi consistently increased lifespan at
25C, but not at 20C, despite ameliorating senescent pathol-
ogies at both temperatures (Figures 4A, 4C, 6B, 6C, and S5A;
Data S3). In another study, where RNAi was performed on 14
autophagy genes and in many cases increased lifespan [40], a
high concentration of 5-fluoro-2-deoxyuridine (FUDR) was
used. Given that intestinal autophagy can protect C. elegans
against bacterial infection [42], a possibility is that FUDR
can alleviate life-limiting infection by co-cultured E. coli that
autophagy protects against; autophagy also appears to
protect C. elegans against end-of-life loss of intestinal barrier
function [43].
Autophagy may also exert life-shortening and life-extending
effects at different times inC. elegans life history. Reduced auto-
phagy during development can impair health [40, 44], whereas
late-life knockdown of autophagy genes can increase lifespan
[41]. Effects of autophagy knockdown on lifespan may also
depend upon severity of knockdown. The adult hermaphrodite
intestine exhibits relatively high levels of autophagy [26] and pro-
tein turnover [45]; we speculate that high intestinal autophagy
levels that maximize yolk production exceed homeostatic re-
quirements, such that partial inhibition of autophagy can improve
late-life health, whereas full abrogation impairs essential house-
keeping functions and reduces health. More generally, where
wild-type levels of autophagy promote life-limiting pathology,
moderate inhibition in autophagy may extend lifespan in the
wild-type but shorten it in a long-livedmutant in which autophagy
levels are already reduced [45] to a level that is optimal to prevent
pathology.
Does IIS Increase or Decrease Intestinal Autophagy?
This study suggests a mechanism by which IIS causes visceral
pathology: autophagy-dependent gut-to-yolk biomass conver-
sion (Figure 7F, left). This is different from a prior suggestion
that inhibition of autophagy by IIS promotes aging. The status
of autophagy in daf-2 mutants remains unclear. Fully reliable
means to directly measure autophagic activity in C. elegans
have yet to be developed [37, 44]. For example, autophagosome
numbers in daf-2mutants are increased in the larval hypodermis
and in the adult intestine [36, 37]. This could reflect eitherCurrent Biology 28, 2544–2556, August 20, 2018 2553
increased autophagosome production (increased autophagy) or
a slowing down in autophagosome consumption (decreased
autophagy) [37, 44]. However, autophagy does not appear to
be blocked in the daf-2 mutant intestine (at least, not entirely),
which could imply increased autophagy [37]. Another broad indi-
cator of autophagic activity is protein turnover rate (although this
is also a function of ubiquitin/proteasomal activity). For example,
aging C. elegans show a decline in both autophagy [37] and pro-
tein turnover [45]. However, daf-2 mutants show major reduc-
tions in both protein synthesis [46] and turnover [47, 48]. Thus,
different forms of evidence suggest either increased or
decreased autophagy in daf-2 mutants. Our findings support
the latter view and suggest a mechanism by which autophagy
acts to promote intestinal senescence (gut-to-yolk biomass con-
version). Given that IIS strongly promotes yolk production [19],
intestinal atrophy could result from the combined effects of IIS-
promoted dominance of the translational machinery by vitelloge-
nin synthesis, constitutively high levels of intestinal autophagy
[26, 45], and yolk export [21]. Another possibility is that IIS
promotes coupled protein synthesis and autophagy [39]. In
conclusion, this study provides a new perspective on the role
of autophagy in C. elegans aging, which we hope will usefully
inform future investigations of the topic.
Gut-to-Yolk Biomass Conversion: A Mechanism for
daf-2 Antagonistic Pleiotropy
Aging evolves at least in part as the result of antagonistic pleiot-
ropy (AP), implying that late-life gene action causes senescence,
including senescent pathologies [5, 8]. daf-2 is a gene with
strong AP effects, promoting reproductive growth in early life
and senescent pathology in later life [10]. The finding that IIS pro-
motes gut-to-yolk biomass conversion provides a mechanistic
account of how IIS-determined AP is enacted, as follows. In early
adulthood, IIS promotes gut-to-yolk biomass conversion, which
increases reproductive fitness by boosting yolk production ca-
pacity. Supporting this, combined knockdown of autophagy
and vitellogenesis strongly reduces fertility (Figure 6G), and pro-
tein turnover rate is reduced in daf-2mutants [46, 47]. Continued
gut-to-yolk biomass conversion later in adulthood leads to pa-
thologies in the form of intestinal atrophy and yolk-derived
PLPs, which can shorten lifespan (Figure 7F, right).
Our findings raise the question: why do hermaphrodites not
turn off gut-to-yolk biomass conversion after cessation of repro-
duction? Here the evolutionary theory suggests a possible
answer: that such an off switch did not evolve due to the reduced
force of natural selection in post-reproductive animals. By this
view, biomass conversion is simply left on, in an open-faucet-
type mechanism, an example of process run-on or hyper-func-
tion [5, 9, 14], where continued yolk production after reproduc-
tion in self-fertilizing hermaphrodites is futile in fitness terms.
However, it remains possible that later yolk production does pro-
mote fitness, e.g., in mated hermaphrodites, which have a longer
reproductive period.
Run-on also contributes to otherC. elegans senescent pathol-
ogies that are promoted by IIS, including run-on of embryoge-
netic programs in unfertilized oocytes, which promotes tumor
development [34, 49], and germline apoptosis, which promotes
gonad atrophy [9]. That IIS promotes mechanistically very
distinct hyper-functions as part of the hermaphroditic reproduc-2554 Current Biology 28, 2544–2556, August 20, 2018tive program suggests that run-onmechanismsmay be typical of
the way that IIS promotes aging.
Conclusions
This study defines a syndrome of senescent multimorbidity
driven by wild-type gene action in which atrophy of a source tis-
sue is coupled by ectopic fat deposition to pathology in other,
sink tissues. Possible generalization of this type of etiology is
suggested by parallels with bone erosion in lactating mammals,
which ensures sufficient calcium in milk [50]. In humans, meno-
pause-associated run-on of such bone-to-milk calcium transfer
may contribute to both osteoporosis and conditions promoted
by ectopic Ca2+ deposition, such as vascular calcification and
osteoarthritis. More broadly, these investigations demonstrate
how senescent pathologies can be generated by the futile sus-
tained activity of wild-type biological programs [5, 8], rather
than by passive and stochastic wear and tear processes.
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Bacterial and Virus Strains
OP50 Escherichia coli B strain (Uracil auxotroph) Caenorhabditis Genetics Center OP50
PY79 Bacillus subtilis strain F. Cabreiro, University College London PY79
Critical Commercial Assays
Triglyceride Quantification Colorimetric/Fluorometric Kit BioVision, Milpitas, California #K622
BODIPY 493/503 (4,4-difluoro-1,3,5,7,8-pentamethyl-4-bora-3a,4a-
diaza-s-indacene)
Fisher Scientific, Loughborough,
United Kingdom
#D3922
Sample Buffer, Laemmli 2X Concentrate Sigma, St Louis, Missouri #S3401
Criterion XT pre-cast gels 4-12% Bis-Tris Biorad, Hercules, California #3450124
XT MOPS running buffer Biorad, Hercules, California #1610788
CelLytic M Biorad, Hercules, California #C2978
Experimental Models: Organisms/Strains
N2 wild type Caenorhabditis Genetics Center N2
CB3168 him-1(e879); mab-3(e1240) Caenorhabditis Genetics Center CB3168
CF80 mab-3(mu15); him-5(e1490) Caenorhabditis Genetics Center CF80
DH26 rrf-3(b26) Caenorhabditis Genetics Center DH26
DR466 him-5(e1490) Caenorhabditis Genetics Center DR466
DR1563 daf-2(e1370) Caenorhabditis Genetics Center DR1563
DR1572 daf-2(e1368) Caenorhabditis Genetics Center DR1572
GA507 glp-4(bn2) daf-16(mgDf50) D. Gems, University College London GA507
GA1500 bIs1[pvit-2::vit-2::GFP + rol-6(su1006)] D. Gems, University College London GA1500
GR1307 daf-16(mgDf50) Caenorhabditis Genetics Center GR1307
GA1711 wuEx272[pvit-6::vit-6::mCherry + rol-6] D. Gems, University College London GA1711
GA1715 wuEx280[rol-6] D. Gems, University College London GA1715
GA1729 atg-13(bp414);wuEx292[pges-1::atg-13 + rol-6] D. Gems, University College London GA1729
GA1730 atg-13(bp414); wuEx293[pges-1::atg-13 + rol-6] D. Gems, University College London GA1730
GA2100 bIs1[pvit-2::vit-2::GFP + rol-6]; wuEx277[pvit-6::vit-6::mCherry +
rol-6]
D. Gems, University College London GA2100
HZ1683 him-5(e1490); atg-2(bp576) Caenorhabditis Genetics Center HZ1683
HZ1685 atg-4.1(bp501) Caenorhabditis Genetics Center HZ1685
HZ1688 atg-13(bp414) Caenorhabditis Genetics Center HZ1688
LIU1 ldrIs1 [pdhs-3::dhs-3::GFP + unc-76(+)] Caenorhabditis Genetics Center LIU1
LSC897 ceh-60(lst466) L. Temmerman, KU Leuven LSC897
LSC903 ceh-60(lst491) L. Temmerman, KU Leuven LSC903
LSC904 lrp-2(lst464) L. Temmerman, KU Leuven LSC904
RT311 unc-119(ed3); pwIs69 [vha6p::GFP::rab-11 + unc-119(+)] Caenorhabditis Genetics Center RT311
RT476 unc-119(ed3); pwIs170 [vha6p::GFP::rab-7 + Cbr-unc-119(+)] Caenorhabditis Genetics Center RT476
RT525 unc-119(ed3); pwIs206 [vha6p::GFP::rab-10 + Cbr-unc-119(+)] Caenorhabditis Genetics Center RT525
RT1315 unc-119(ed3); pwIs503 [pvha-6::mans::GFP + Cbr-unc-119(+)] Caenorhabditis Genetics Center RT1315
SS104 glp-4(bn2) Caenorhabditis Genetics Center SS104
VC893 atg-18(gk378) Caenorhabditis Genetics Center VC893
VP303 rde-1(ne219); kbEx200 [pnhx-2::rde-1] Caenorhabditis Genetics Center VP303
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EXPERIMENTAL MODELS AND SUBJECT DETAILS
C. elegans Culture and Strains
C. elegansweremaintained under standard conditions [53], at 20C on NGMplates seeded with Escherichia coliOP50, unless other-
wise stated. For Bacillus subtilis trials the PY79 strain was used. Some RNAi experiments were performed at 25C. Hermaphrodites
were used except when otherwise stated. Males were cultured at low density (5 per plate) during aging trials to reduce detrimental
effects of male-male interactions [54].
The following strainswere used: N2 (wild-typeN2male stock, N2CGCM) [55]; CB3168 him-1(e879); mab-3(e1240) [56], CF80mab-
3(mu15); him-5(e1490), DH26 rrf-3(b26), DR466 him-5(e1490), DR1563 daf-2(e1370), DR1572 daf-2(e1368), GA507 glp-4(bn2) daf-
16(mgDf50), GA1500 bIs1[pvit-2::vit-2::GFP + rol-6(su1006)], GR1307 daf-16(mgDf50), HZ1683 him-5(e1490); atg-2(bp576),
HZ1685 atg-4.1(bp501), HZ1688 atg-13(bp414), LIU1 ldrIs1 [pdhs-3::dhs-3::GFP + unc-76(+)], LSC897 ceh-60(lst466), LSC903
ceh-60(lst491), LSC904 lrp-2(lst464), RT311 unc-119(ed3); pwIs69 [vha6p::GFP::rab-11 + unc-119(+)], RT476 unc-119(ed3);
pwIs170 [vha6p::GFP::rab-7 + Cbr-unc-119(+)], RT525 unc-119(ed3); pwIs206 [vha6p::GFP::rab-10 + Cbr-unc-119(+)], RT1315
unc-119(ed3); pwIs503 [pvha-6::mans::GFP + Cbr-unc-119(+)], SS104 glp-4(bn2), VC893 atg-18(gk378), VP303 rde-1(ne219);
kbEx200 [pnhx-2::rde-1]. The following strains were created for this study: GA1711 wuEx272 [pvit-6::vit-6::mCherry + rol-6],
GA1715 wuEx280[rol-6], GA1729 atg-13(bp414); wuEx292[pges-1::atg-13 + rol-6], GA1730 atg-13(bp414); wuEx293[pges-
1::atg-13 + rol-6], GA2100 bIs1[pvit-2::vit-2::GFP + rol-6]; wuEx277[pvit-6::vit-6::mCherry + rol-6].
METHOD DETAILS
Pathology Measurements
Worms were mounted onto 2% agar pads and anesthetized with 0.2% levamisole. Nomarski microscopy images were acquired with
an Orca-R2 digital camera (Hamamatsu) and either a Leica DMRXA2 microscope or a Zeiss Axioskop 2 plus microscope, driven by
Volocity 6.3 software (Improvision, Perkin-Elmer). Images of pathology were analyzed semiquantitatively [13, 57] (Figures S1A–S1E).
For pharynx, gonad and tumor pathologies, images were randomized, examined, assigned scores of 1-5 by two independent
scorers, andmean values calculated and rounded. Here 1 = youthful, healthy appearance; 2 = subtle signs of deterioration; 3 = clearly
discernible, mild pathology; 4 = well developed pathology; and 5 = tissue so deteriorated as to be barely recognizable (e.g., gonad
completely disintegrated), or reaching amaximal level (e.g., large tumor filling the entire bodywidth). Intestinal atrophywas quantified
by measuring the intestinal width at a point posterior to the uterine tumors, subtracting the lumenal width and dividing by the body
width. Yolk accumulation was measured by dividing the area of yolk pools with the area of the body visible in the field of view at 630x
magnification.
Single Worm, Longitudinal Pathology Analysis
Worms were cultured individually at 20C. On days 4, 7, 11, 14 and 18 of adulthood, each wormwas imaged individually by Nomarski
microscopy (Figures S1F and S1G). For imaging, microscope slides were prepared by taping two coverslips on the slide, at each
edge, leaving an empty space in the middle for the agarose pad. The worm was then placed on a 2% agarose pad on the slide.
Another coverslip was then placed on top, but resting on the two side coverslips, to reduce the pressure of the coverslip onto the
worm. The slide was then placed on a PE120 Peltier cooling stage (Linkam Scientific) set to 4C. Within minutes of cooling the nem-
atodes ceased tomove, and images were taken at 630xmagnification using a Zeiss Axioskopmicroscope. After imaging, each worm
was carefully recovered by pipetting 20 mL of M9 buffer between the top coverslip and the agar pad. The coverslip was then gently
removed and the worm picked onto an NGM plate. Images of pharynxes, distal gonads, uterine tumors, PLPs and intestinal atrophy
were analyzed as described above. The lifespan of each nematode was then measured.
Bodipy Staining
This was performed as described [18], except that worms were manipulated in 15 mL droplets held in parafilm micro-wells. Briefly,
animals were washed 2x by transferring them successively into two droplets of M9 using a platinum wire pick. They were then trans-
ferred to a drop of 2% paraformaldehyde solution for 15-20 min and frozen/thawed 3x at 80C/room temperature (RT). Animals
were then carefully washed 3x by transferring them into successive M9 droplets. They were then transferred to 1 mg/mL BODIPY
493/503 (Invitrogen) in M9 solution for 1-2 hr at RT in darkness. The worms were finally washed 3x in M9 droplets and mounted
for imaging (488 nm Exc./505-575 nm Em.) on a Zeiss LSM710 confocal microscope.e2 Current Biology 28, 2544–2556.e1–e5, August 20, 2018
Lifespan Measurements
Thesewere performed at 20Cor 25C.Wormswere either transferred daily during the reproductive period, or transferred at L4 stage
to plates supplemented with 15 mM FUDR to block progeny production. Animals that died from internal hatching were censored. For
atg-13 RNAi lifespan trials, blind scoring was performed.
Generation of Transgenic Strains
Constructs were made using PCR fusion using primers as follows (a full list of primers is also provided in Table S2). To generate the
vit-6::mCherry strain, where mCherry is fused to the C terminus of VIT-6, the 6,740 bp vit-6 promoter and genomic region, excluding
the stop codon, was amplified using F: 50-TTCTTCTTTCGGTGGCTCTG-30 and R: 50-CTTCTTCACCCTTTGAGACCATATAGTC
GAACTTGTCGCACT-30. mCherry was amplified using F: 50-ATGGTCTCAAAGGGTGAAGAAG-30 and R: 50-GATGGCGATCTGAT
GACAGC-30. The 30UTR was amplified using F: 50-CTACCTCTTCTTCACAATCATACAC-30 and R: 50-ACTGTAGAAGTGA
ACTCTGTG-30. The vit-6 fragment was fused to mCherry using F: 50-TGGAGACACAATAGAAGTCG-30 and R: 50-GTGTATGATTGT
GAAGAAGAGGTAGCTACTTATACAATTCATCCATGCCAC-30. The fused fragment was further fused with the 30UTR using F:
50-ATTCCACAGAAAGGATTGCAC-30 and R: 50-ATGCCGAGTTGTTTGAATTG-30. For the atg-13 intestinal rescue, the ges-1 pro-
moter was amplified using F: 50-TTGTCTATTGGTATGGCTGC-30 and R: 50-GTACGTGTCGTACTCATTTACCATACAAGGAA
TATCCGCATCTG-30. The atg-13 2,300 bp genomic region was amplified using F: 50-ATGGTAAATGAGTACGACACGTAC-30 and
R: 50-TGCAAGACTTCTGAGCAATG-30. The two fragments were fused using primers F: 50-GCGCTACCAATAAGGCTAAG-30 and
R: 50-GAGCAATGTCGCAATGGAAAG-30. vit-6::mCherry was microinjected at 1 mg/mL with 100 mg/mL rol-6 coinjection marker to
generate GA1711. GA1711 was crossed with GA1500 to obtain GA2100. VIT-6 is proteolytically cleaved, yielding YP115 and
YP88 [58]. The VIT-6::mCherry fusion protein was 139 kDa in size (data not shown), consistent with YP115 being the C-terminal
portion of VIT-6, as shown by protein sequence data obtained from YP115 [59]; i.e., mCherry is fused to YP115. pges-1::atg-13
was injected into atg-13(bp414) at 80 mg/mL with 20 mg/mL rol-6 coinjection marker. Two independent lines, GA1729 and GA1730,
were used for experiments.
Electrophoretic Analysis of Yolk Proteins
Yolk protein levels were quantified by running worm protein extracts on PAGE gels and then staining with Coomassie blue dye as
described [19]. 20 worms were picked into 25 mL of M9 buffer and frozen at 80C. Samples where then thawed, and 25 mL of 2x
Laemmli sample buffer (Sigma) added. Samples were incubated at 70C, vortexed continuously for 15 min, incubated at 95C for
5 min and spun at 6,000 rpm for 15 min. Samples were loaded onto Criterion XT precast gels 4%–12% Bis-Tris (Bio-Rad), using
XT MOPS (Bio-Rad) as a running buffer, and stained and destained following standard protocols. Gels were analyzed using
ImageQuant LAS-4000 (GE Healthcare). Protein band identification was based on published data [19, 21]. YP170, YP115 and
YP88 were previously identified as vitellogenins by means of peptide mapping [60]. Correct identification in the present study of
vitellogenins on protein gels was confirmed by the effect of vit-5,6 RNAi, which abrogated YP170, YP115 and YP88 accumulation
(Figure S4A). Yolk proteins were normalized to myosin and the ratio of actin to myosin was estimated to assess the reliability of
myosin as a standard for normalization [19].
Yolk Protein Proportion Measurements
Two approaches were taken to estimate the proportion of total worm protein that is yolk protein: using densitometry or reference to
protein standards of known concentration. For the densitometry-based approach, the density of individual vitellogenin bands
(YP170, YP115 and YP88), and of the entire lane, of protein gels stained with Coomassie Blue weremeasured. The density of a whole
lane (all protein) was set as 100%, and the percentages of the vitellogenin bands were calculated proportionally. The optimal
threshold for densitometric reading was that which was just sufficient to exclude background from regions between gel lanes. For
the protein standard-based approach, known amounts of protein standard were run alongside worm protein samples and gels
stained with Coomassie Blue. The density of bands obtained from standard protein was used to construct a standard curve. The
intensity of vitellogenin bands (YP170, YP115 and YP88) from the samples was then compared to the standard curve, to calculate
the amounts of vitellogenin protein present. To estimate the proportion of yolk proteins to total protein, the estimated amount of yolk
protein was compared with total protein content data obtained from protein quantification using BCA.
Total Nematode Protein Measurement
This was performed using bicinchoninic acid (BCA). Samples were prepared by adding 250 mL of CelLyticMbuffer (Sigma) containing
1:1000 protease inhibitor cocktails. Sampleswere thenmixed and sonicated using aBioruptor (CosmoBio, Tokyo, Japan) for 8min at
30 s intervals. Samples were centrifuged at 4C at 6000 rpm for 15 min. The BCAmethod was performed in a 96-well plate, with each
well containing 200 mL of testing solution and 25 mL sample or bovine serum albumin (BSA) standards. The plate was mixed gently
and incubated at room temperature for 2 min and then incubated at 37C for 30 min. Absorbance was then measured at 620 nm.
Confocal Microscopy
Bodipy stained animals were mounted on an 2.5% agarose pad between slide and coverslip in M9. 25-35 mm thick Z stacks were
acquired every 0.75 mm through Zeiss Plan-Apochromat 40X or 63X 1.4 immersion lenses using Zeiss LSM710 (UCL) and
LSM880 (LU) confocal microscopes equipped with 405 nm, 488 nm, 568 nm and 633 nm lasers, and controlled by the Zen softwareCurrent Biology 28, 2544–2556.e1–e5, August 20, 2018 e3
package. Bodipy, VIT-2::GFP, DHS-3::GFP and MANS-2::GFP were imaged using the 488 nm laser, while VIT-6::mCherry was
imaged using the 568 nm laser. Confocal image analysis of Bodipy staining focused on the int1, 2 and 3 gut cells, averaging
fluorescence from 7 consecutive Z-planes that passed through the intestinal lumen. Within the ROI, segmentation in intestinal
and non-intestinal areas was performed plane by plane comparing brightfield and fluorescence images across the Z stack to delin-
eate the intestinal limits. For DHS-3::GFP and MANS-2::GFP, scoring systems were established using a scale of 0 to 10 for
DHS-3::GFP and 0 to 5 for MANS-2::GFP, with 0 representing no significant staining and 10 or 5 representing even and bright label-
ing. Intermediate scores correspond to various degrees of signal amount (area), density, heterogeneity and sharpness. The results
shown are the average of two rounds of scoring for each dataset. Each confocal microscopy experiment combines 2 to 4 indepen-
dent replicates of 5 to 30 worms for each genotype/time point combination. As fluorescence levels and dynamics vary between
worms and slides, fluorescence intensity cannot be reliably related to lipid amounts, which is why lipid organelle area was chosen
over fluorescence intensity as a quantitative measure. All fluorescence quantifications were performed on raw images while illustra-
tions in supplemental figures were saturated to enable easy visualization.
Electron Microscopy
30-40 adult worms per condition were pre-fixed in a drop of 2% low-melting point agarose solution (kept below 30C on a heat block)
containing 2.5% glutaraldehyde, 1% paraformaldehyde in 0.1M sucrose, 0.05M cacodylate, and 0.02% levamisole. Worms were
moved to a dissecting scope at room temperature and quickly aligned as the agarose set, and then cut in half using a razor blade.
Half worms were realigned upon addition of another drop of melted agarose, and the gelled block was then trimmed before trans-
ferring into the fixative solution (2.5% glutaraldehyde, 1% paraformaldehyde in 0.1M sucrose, and 0.05M cacodylate) on ice. The
agarose block was then stained and processed as described [61] (protocol 8), adjusting timings to account for slower diffusion
through the agarose block. Serial 1 mm sections were taken for light microscopy inspection, and ultra-thin (70-80 nm) sections
were cut at the region of interest using a diamond knife on a Reichert ultramicrotome. Sections were collected on slot grids and
stained with lead citrate before viewing using a Joel 1010 transition electron microscope. Images were captured with a Gatan Orius
camera and Gatan imaging software, and then exported in TIFF format.
Total Triacylglyceride Quantification
Biovision’s Triglyceride Quantification Kit (Mountain View, CA) was used to assay for triacylglyceride content. Animals were aged and
counted before harvest. Samples contained approximately 300 animals in 100 mL Biovision assay buffer and were frozen in liquid
nitrogen and thawed 100C 3 times, followed by sonication to break the cuticle. Lipids were extracted in glass tubes with the Folch
method and reconstituted in 100 mL assay buffer. Triacylglycerides were measured using the kit protocol.
Lipid Extraction and Mass Spectrometry Analysis
Lipidomic analysis was performed on about 3,000 to 10,000worms per sample.Wormswere counted and collected inM9buffer. This
was followed by washing: samples were centrifuged at 1000 rpm for 3min, to pellet the worms while leaving the bacteria in suspen-
sion. As much as possible of the supernatant was removed without disturbing the worm pellet and fresh M9 was then added. The
process was repeated several times, until the supernatant was clear and free of bacteria. After a final wash in PBS, the worm pellet
was resuspended in 1mL PBS and frozen at 80C. The samples were thawed while vortexing at room temperature and transferred
to 10mL silanized glass tubes using silanized glass pipettes. 1mL methanol and 2mL chloroform were added to each sample and
vortexed to mix. 40 mL of lipid standard mixture (12:0/12:0/12:0-triacylglycerol [TG; 800 ng]) was used to spike each sample. After
thorough mixing, samples were subjected to a modified Folch extraction. The lipid extracts were dissolved in 150 mL chloroform
in silanised glass sample vials. 7 mL of sample was injected for positive ion lipids analysis and another 7 mL was injected for negative
ion lipids analysis. In brief, different classes of lipids were separated on a normal phase Type C silica gel column (1503 2.1mm, 4 mm,
100A˚, MicoSolv Technology) with hexane/dichloromethane/chloroform/methanol/acetanitrile/water/ethylamine solvent gradient
elution based on the polarity of head group using a Shimadzu Prominence HPLC system. Individual lipid species were identified
and semi-quantified with high resolution (240 k at m/z 400) accurate mass analysis (mass accuracy < 5ppm) on a Thermo Orbitrap
Elite mass spectrometer.
Intestinal Autophagy Assays
These were performed using strain DLM3 ttTi5605 II; unc-119(ed3) III; uwaEx2 [vha-6p::CERULEAN-VENUS::lgg-1 + unc-119(+)], as
described [26]. Animals were maintained on E. coli HT115 and the test group subjected to atg-13 RNAi from L4 onward (20C). This
strain has intestine-limited expression of dFP (dimer) which contains two fluorescent protein-tagged monomers of the LGG-1 auto-
phagosomal membrane protein. Upon autophagosome-lysosome fusion dFP is cleaved into mFP (monomer); thus, mFP/dFP ratio
provides a relative measure of autolysosome formation.
Mating and Male Scent Exposure Tests
To test effects of mating on pathology, single hermaphrodites were mated with 3 males. On day 3, males were removed and mated
hermaphrodites subsequently identified by the presence of male progeny, and thenmaintained for pathology analysis. To test effects
of male scent, 60mm NGM plates were conditioned with males for 2 days. Males were then removed and hermaphrodites added.e4 Current Biology 28, 2544–2556.e1–e5, August 20, 2018
Plates were either conditioned with 150 males and then 30 hermaphrodites added, or with 60 males and then 30 hermaphrodites
added. In a further protocol, 35mm NGM plates were conditioned with 30 males to which 30 hermaphrodites were added.
QUANTIFICATION AND STATISTICAL ANALYSIS
Pathology Measurements
The Student’s t test was used. ANOVA and two-way ANOVA with Bonferroni correction were applied to take into account multiple
comparisons. Correlations from single worm, longitudinal pathology analysis were analyzed using the Spearman Rank test and linear
regression analysis. Benjamini-Hochberg corrections were used for multiple comparisons.
Survival Analysis
Statistical significancewas estimated using log rank andWilcoxon statistical tests executed using JMP 11 software (Data S3). Unless
stated otherwise, three independent trials with N > 10 in each trial were used. All graphs display mean values and all error bars depict
standard error of the mean (SEM).Current Biology 28, 2544–2556.e1–e5, August 20, 2018 e5
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Figure  S1.  Measurement  of  severity  of  senescent  pathology.  Related  to  Figure  1.  (A-­C) For  pharynx  (A),  gonad  (B)  and  
uterine  tumor  (C)  pathologies,  images  were  randomized,  and  given  scores  of  1-­5.  Here  1  =  a  youthful,  healthy  appearance;;  2  =  
showing  subtle  signs  of  deterioration;;  3  =  clearly  discernible,  low  level  pathology;;  4  =  well  developed  pathology;;  and  5  =  tissue  
so  deteriorated  as  to  be  barely  recognizable  (e.g.  gonad  completely  disintegrated),  or  reaching  a  maximal  level  (e.g.  large  tumor  
filling  the  entire  body  diameter).  (D,E)  Pseudocoelomic  lipoprotein  pool  (PLP)  formation  (yolk  accumulation)  (D)  and  intestinal  
atrophy   (E)  were  measured  by   dividing   the   total  area  of  yolk   pools  with   the  area  of   the  body  visible   in   the   field  of  view.   (F)  
Experimental  approach  for  measuring  correlation  between  severity  of  senescent  pathologies  and  lifespan,  by  combining  serial  
imaging  of  pathology  in  individual  nematodes,  and  then  measuring  their  lifespan.  (G)  Examples  of  images  of  pathology  at  one  of  
the  time  points  examined  (day  7).    
  
     
  
Figure  S2.  Senescent  pseudocoelomic  lipoprotein  pool  accumulation  and  intestinal  atrophy.  Related  to  Figure  2.  (A)  Co-­
occurrence  of  PLP  accumulation  (upper  panels)  and  intestinal  atrophy  (lower  panels)  with  age  occurs  at  all  temperature  tested  
(far  left),  on  E.  coli  K12  diets  (center-­left),  on  a  Bacillus  subtilis  diet  (center-­right),  and  in  presence  of  FUDR  (far  right).  (B)  PLP  
accumulation  score  and  intestinal  atrophy  correlate  at  the  individual  worm  level  at  25˚C  with  FUDR.  (C)  Columns  from  left  to  right:  
brightfield,   VIT-­2::GFP,   VIT-­6::mCherry,   VIT-­2::GFP   +   VIT-­6::mCherry   merged.   Day   1   adults   show   VIT-­2::GFP   and   VIT-­
6::mCherry  in  the  intestine  (200X  magnification)  (top).  Day  1  adults  show  VIT-­2::GFP  and  VIT-­6::mCherry  in  the  intestine  and  
embryos  (100X)  (middle).  Day  8  adults  show  VIT-­2::GFP  and  VIT-­6::mCherry  in  the  intestinal  droplets  and  PLPs  (100X)  (bottom).  
VIT-­2::GFP  was  also  observed  in  the  tumors  and  VIT-­6::mCherry  in  the  coelomocytes.  (D)  Columns  from  left  to  right:  brightfield,  
Bodipy,  VIT-­6::mCherry,  and  Bodipy  +  VIT-­6::mCherry  merged.  Day  10  adults,  epidermal   level,  show  Bodipy  staining  of   lipid  
droplets  within  muscles  (200X)  (top).  Day  10  adults,   intestinal   level,  show  yolky  lipid  within  and  outside  of  the  intestine  (200X)  
(bottom).    
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Figure  S3.  Alterations  in  lipid  content.    Related  to  Figure  2.  (A)  Quantification  of  total  triacylglyceride  (TAG)  content,  which  
increases  5-­fold  between  day  1  and  day  7  in  wild-­type  hermaphrodites  maintained  on  E.  coli  HT115.  (B)  Mass  spectroscopy  
analysis  of  age  changes  in  lipid  profiles.  In  wild-­type  at  20˚C  TAG  content  increases  8.2  fold  (top).  In  sterile  rrf-­3(b26)  mutants  at  
25˚C  TAG  content  increases  5.0  fold  (bottom).    
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Figure  S4.  Vitellogenin  accumulation  and  intestinal  atrophy  in  aging  hermaphrodites.  Related  to  Figure  3.  (A)  
Representative  Coomassie  stained  gels  showing  the  age-­increase  in  yolk  protein  (YP)  (vitellogenin)  levels  in  N2  
hermaphrodites  (top  left),  and  prevention  of  YP170,  YP115  and  YP88  accumulation  after  vit-­5,6  RNAi  (top  right,  bottom;;  note  
that  the  original  gel  included  4  samples  for  each  day,  2  of  which  were  subsequently  cropped  from  the  image,  since  they  showed  
other  RNAi  tests  that  are  not  relevant  here).  (B,C)  Vitellogenin  accumulation  continues  after  reproduction  despite  a  declining  
feeding  rate.  (B)  Age  decline  in  pharyngeal  pumping  rate.  (C)  Quantification  of  YP  proportion  of  total  protein  using  protein  
standards.  According  to  this  method,  YP  protein  proportion  increases  from  <10%  on  day  1  to  ~35%  on  day  8.  (D)  Reduced  
accumulation  of  PLPs  in  ceh-­60  and  lrp-­2  mutants.  (E)  Decrease  with  age  in  intestinal  lipid  content,  measured  with  the  
fluorescent  stain  Bodipy.  Trials  conducted  at  25˚C  with  15µM  FUDR.  (F,G)  Effects  on  intestinal  atrophy  of  blocking  bacterial  
proliferation  with  UV  irradiation  (F)  or  4mM  carbenicillin  (G).  Both  treatments  cause  a  delay  but  not  a  reduction  in  intestinal  
atrophy.     
  
  
Figure  S5.  Inhibition  of  autophagy  reduces  visceral  pathologies  in  aging  hermaphrodites.  Related  to  Figure  4.  (A)  Adult-­
limited  atg-­13  RNAi  suppresses  intestinal  atrophy  (left,  center)  and  PLP  accumulation  (right).  The  decline  in  relative  intestinal  
width  is  reduced  at  20˚C,  no  FUDR  (left),  and  at  25˚C,  15µM  FUDR  (center).  Suppression  of  PLP  accumulation,  25˚C,  15µM  
FUDR  (right).  (B)  Intestine-­specific  rescue  of  atg-­13(bp414)  restores  intestinal  atrophy  to  wild-­type  levels,  25˚C,  no  FUDR  (left)  
though  not  PLP  accumulation  (right).  (C)  Adult-­limited  inhibition  of  autophagy  delays  DHS-­3::GFP-­tagged  intestinal  lipid  droplet  
reduction,  N=2  trials.  (D)  atg-­4.1(bp501          )  (left)  and  atg-­2(bp576)  (right)  (autophagy  defective)  retard  senescent  redistribution  
of  lipids  (Bodipy  staining);;  **  p<0.01,  ***  p<0.001,  comparison  to  day  1;;  &  p<0.05,  &&&  p<0.001,  comparison  to  age-­matched  
control   (shown   in   Figure  G3).   (E)  Adult-­limited   inhibition   of   autophagy  delays   intestinal  atrophy,  N=2   trials.  F)  atg-­13(bp414)  
reduces  the  age-­associated  lipidomic  shift  occurring  between  day  1  and  day  6  of  adulthood;;  25˚C,  15µm  FUDR.  (G)  Quantification  
of  Golgi   abundance   using  MANS::GFP.  Age-­related   decrease   in  Golgi   abundance   is  suppressed   by  atg-­13  RNAi.   (H)  Adult-­
limited  atg-­2  RNAi  or  atg-­13  RNAi  increase  while  atg-­18  RNAi  decreases  lifespan;;  25˚C,  15µm  FUDR.  (I)  Adult-­limited  rme-­2  
RNAi  decreases  lifespan;;  25˚C.  (J)  fat-­6/7  RNAi  increases  intestinal  atrophy,  N=2  trials.    
     
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Figure  S6.  Effects  of  mating  and  exposure  to  males  on  visceral  pathology.  Related  to  Figure  6.  (A,B) Effects  of  mating  on  
intestinal  pathology  (A)  and  PLP  accumulation  (B).  Each  hermaphrodite  was  mated  with  3  males  for  3  days.  (C-­H) Effects  of  
exposure  to  male  scent  on  intestinal  pathology  and  PLP  accumulation.  Conditioning  experiments  were  performed  with  different  
ratios   of   conditioning   males   and   assayed   hermaphrodites.   (C,D)   150   males:30   hermaphrodites.   (E,F)   30   males:30  
hermaphrodites.  (G,H)  60  males:30  hermaphrodites  (35mm  plates).    
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Figure  S7.  Gut-­to-­yolk  biomass  conversion  results  in  gut  atrophy  and  PLP  accumulation.  Related  to  Figure  7.  (A)  Left:  
Nomarski  image  of  an  N2  hermaphrodite  mid-­body  at  day  14  of  adulthood  (20˚C),  showing  atrophied  intestine  and  PLPs.  Right:  
age-­matched   daf-­2(e1370)  mutant   mid-­body.   Note   full-­sized   intestine   and   absence   of   PLPs   (representative   images).   (B)  
Comparison   of   total   protein   contents   during   aging   in   age-­matched   wild   type,  daf-­2(e1368)  and  daf-­2(e1370)  mutants.  daf-­
2  mutant  protein  content  increases  much  less  with  age  than  wild  type.  (C)  Representative  pictures  of  gentle-­fix  Bodipy  staining  
in  the  anterior  intestine  and  surrounding  tissues  in  daf-­16(mgDf50)  (left),  daf-­2(e1370)  (middle),  and  daf-­16;;  daf-­2  mutants  (right),  
illustrating  DAF-­16-­dependent  preservation  of  intestinal  fat  stores  and  prevention  of  fat  transfer  in  daf-­2  mutants  at  days  1,  4  and  
8  of  adulthood  at  25˚C.  (D)  Blocking  germline  growth  using  glp-­4(bn2)  delays  intestinal  atrophy,  and  this  effect  is  largely  daf-­16  
dependent,  25˚C,  N=2  trials.  Statistical  comparisons,  green:  glp-­4  vs.  wild  type;;  blue,  glp-­4  daf-­16  vs.  glp-­4.    
  
  
  
  
  
  
Lipid  species    
(ng  per  worm)  
20˚C  no  FUDR   25˚C  15µM  FUDR  
Wild  
type    
day  1  
Wild  
type    
day  7  
rrf-­3  
day  1  
rrf-­3  
  day  7  
Wild  
type    
day  1  
Wild  
type    
day  6  
atg-­13  
day  1  
atg-­13  
  day  6  
Phosphatidic  acid   0.0197   0.1060   0.0287   0.0664   0.0254   30.4577   0.0280   0.0639  
Phosphatidylcholine   1.8859   6.0791   4.9495   7.0140   1.7199   0.1552   1.6067   1.6504  
Phosphoethanolamine   1.1001   1.7826   1.8407   3.4344   0.6872   2.2187   0.4427   0.6395  
Phosphatidylserine   0.2397   0.8127   1.4856   1.2290   0.1925   0.5967   0.1815   0.2185  
Phosphatidylglycerol   0.1081   0.1725   0.0629   0.1434   0.0526   0.3416   0.0349   0.0488  
Phosphatidylinositol   9.5943   30.0363   23.8472   8.9514   4.2035   0.0330   6.8700   10.6244  
Cardiolipin   0.1187   0.1681   0.0589   0.0686   0.0807   0.0287   0.0708   0.0578  
Ceramides   0.0012   0.0029   0.0085   0.0128   0.0029   0.0036   0.0013   0.0044  
Fatty  acids   64.78   75.82   11.45   20.19   11.61   27.41   10.91   8.43  
Fatty  acyl-­carnitine   0.0002   0.0131   0.0002   0.0109   0.0027   0.0040   0.0021   0.0039  
Diacylglycerol   2.7751   4.5304   4.2648   8.7420   0.7787   1.8314   0.6915   1.1561  
Triacylglycerol   1.5930   13.2132   3.0936   16.7488   1.1455   1.2188   0.9313   0.8023  
Fatty  acyl-­CoA   13.479   14.470   -­   -­   0.290   1.599   0.183   0.181  
Sphingomyelin   0.0637   0.2101   -­   -­   0.0480   0.1352   0.0536   0.1271  
Others   4.858   12.967   12.477   5.577   1.448   5.007   2.197   2.254  
TOTAL   100.62   160.39   63.56   72.19   22.28   71.04   24.21   26.26  
    
"-­"  indicates  missing  values  (compromised  samples).  
  
Table  S1.  Lipid  profiles  of  young  and  middle-­aged  C.  elegans  hermaphrodites.  Related  to  Figure  5.  Genotypes  tested  are  
wild  type  (N2),  rrf-­3(b26)  (temperature-­sensitive  sterile)  and  atg-­13(bp414).    
     
Primer  target  DNA   Direction   5'  to  3'  primer  sequence  
vit-­6  (promoter  +CDS)   Forward   TTCTTCTTTCGGTGGCTCTG  
vit-­6  (promoter  +CDS)   Reverse   CTTCTTCACCCTTTGAGACCATATAGTCGAACTTGTCGCACT  
mCherry   Forward   ATGGTCTCAAAGGGTGAAGAAG  
mCherry   Reverse   GATGGCGATCTGATGACAGC  
3'UTR   Forward   CTACCTCTTCTTCACAATCATACAC  
3'UTR   Reverse   ACTGTAGAAGTGAACTCTGTG  
vit-­6::mCherry  fusion   Forward   TGGAGACACAATAGAAGTCG  
vit-­6::mCherry  fusion   Reverse   GTGTATGATTGTGAAGAAGAGGTAGCTACTTATACAATTCATCCATGCCAC  
vit-­6::mCherry::3'UTR  fusion   Forward   ATTCCACAGAAAGGATTGCAC  
vit-­6::mCherry::3'UTR  fusion   Reverse   ATGCCGAGTTGTTTGAATTG  
ges-­1  (promoter)   Forward   TTGTCTATTGGTATGGCTGC  
ges-­1  (promoter)   Reverse   GTACGTGTCGTACTCATTTACCATACAAGGAATATCCGCATCTG  
atg-­13  (CDS)   Forward   ATGGTAAATGAGTACGACACGTAC  
atg-­13  (CDS)   Reverse   TGCAAGACTTCTGAGCAATG  
ges-­1p::atg-­13  fusion   Forward   GCGCTACCAATAAGGCTAAG  
ges-­1p::atg-­13  fusion   Reverse   GAGCAATGTCGCAATGGAAAG  
  
  
Table  S2.  Oligonucleotides  used  to  produce  PCR  fusions  for  transgenic  strain  generation.  Related  to  STAR  Methods.  
The  promoter  of  vit-­6  and  coding  genomic  sequence  were  fused  to  mCherry  coding  sequence  and  vit-­6  3’UTR  in  5  sequential  
PCR  reactions  (10  first  primers).  atg-­13  genomic  coding  sequence  was  fused  to  the  ges-­1  promoter  for  the  gut-­specific  rescue  of  
ATG-­13  expression  in  atg-­13(bp414)  mutants  (6  last  primers).    
 
 
  
  
